Related references
Note: Only part of the references are listed.Receptor tyrosine kinases with intracellular pseudokinase domains
Jeannine M. Mendrola et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Activation of Wnt5a-Ror2 signaling associated with epithelial-to-mesenchymal transition of tubular epithelial cells during renal fibrosis
Xin Li et al.
GENES TO CELLS (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
Michael P. O'Connell et al.
CANCER DISCOVERY (2013)
Dissection of Wnt5a-Ror2 Signaling Leading to Matrix Metalloproteinase (MMP-13) Expression
Kaoru Yamagata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour
Badreddin Edris et al.
JOURNAL OF PATHOLOGY (2012)
Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE
Shan-shan Lai et al.
CANCER GENETICS (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
Alessandra Gentile et al.
CANCER RESEARCH (2011)
Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition
Dayong Ren et al.
GENES TO CELLS (2011)
HIF-2α Enhances β-Catenin/TCF-Driven Transcription by Interacting with β-Catenin
Hyunsung Choi et al.
CANCER RESEARCH (2010)
The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma
M. P. O'Connell et al.
ONCOGENE (2010)
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase
H. Yamamoto et al.
ONCOGENE (2010)
Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers
H. Ohta et al.
BRITISH JOURNAL OF CANCER (2009)
Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer
Takashi Kubo et al.
CARCINOGENESIS (2009)
Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
M. Enomoto et al.
ONCOGENE (2009)
Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma
T. M. Wright et al.
ONCOGENE (2009)
Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity
Masaki Kobayashi et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2009)
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
Kiran Gupta et al.
CANCER TREATMENT REVIEWS (2008)
Renal cell carcinoma recurrence after nephrectomy for localized disease: Predicting survival from time of recurrence
Scott E. Eggener et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2
AR Afzal et al.
NATURE GENETICS (2000)
Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B
M Oldridge et al.
NATURE GENETICS (2000)
Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation
S Takeuchi et al.
GENES TO CELLS (2000)
Share Paper
